Sabadell, Spain

Luis Alfonso Rojas Expósito

This inventor holds 2 USPTO granted patents and 1 published patent application. Top assignees: Institut Catala D'oncologia (Ico), Fundacio Institut D'investigacio Biomedica De Bellvitge (Idibell), Fundació Institut D'lnvestigació Biomedica De Bellvitge (Í Dibell). Active years: 2020-2023.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Luis Alfonso Rojas Expósito. Retrieved from https://idiyas.com/inventor/luis-alfonso-rojas-expósito

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 2 

% Patents Active = 100.0

Average Co-Inventor Count = 2.0

ph-index = 1

Forward Citations = 8(Granted Patents)


Company Filing History:


Years Active: 2020-2023

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Luis Alfonso Rojas Expósito: Innovator in Oncolytic Adenovirus Technology

Introduction

Luis Alfonso Rojas Expósito is a notable inventor based in Sabadell, Spain. He has made significant contributions to the field of biotechnology, particularly in the development of oncolytic adenoviruses. With a total of 2 patents, his work focuses on innovative solutions for cancer treatment.

Latest Patents

Rojas Expósito's latest patents include a groundbreaking invention related to adenoviruses. His first patent describes a recombinant adenovirus that features an albumin-binding moiety on the outer surface of the adenoviral hexon protein. This invention also encompasses pharmaceutical compositions containing the adenovirus and its medical applications. Specifically, it relates to an oncolytic adenovirus that includes a sequence encoding an albumin-binding moiety inserted in the hypervariable region 1 (HVR1) of the hexon protein coding sequence. This technology is aimed at the prevention and/or treatment of cancer.

Career Highlights

Throughout his career, Rojas Expósito has worked with esteemed organizations such as the Catalan Institute of Oncology (Institut Català d'Oncologia) and the Bellvitge Biomedical Research Institute (Fundació Institut d'Investigació Biomèdica de Bellvitge). His experience in these institutions has allowed him to advance his research and contribute to significant medical innovations.

Collaborations

Rojas Expósito has collaborated with various professionals in his field, including Ramon Alemany Bonastre. These partnerships have facilitated the exchange of ideas and fostered advancements in cancer research.

Conclusion

Luis Alfonso Rojas Expósito is a prominent figure in the realm of biotechnology, particularly in the development of oncolytic adenoviruses for cancer treatment. His innovative patents and collaborations highlight his commitment to advancing medical science.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…